Skip to content

EV / sales at other companies

Humana logo
HumanaHUM
0.2×-0.1×
CVS Health logo
CVS HealthCVS
0.2×0.0×
UnitedHealth Group logo
UnitedHealth GroupUNH
0.7×-0.6×
Centene logo
CenteneCNC
0.1×-0.1×
Cigna logo
CignaCI
0.2×0.0×
Cencora logo
CencoraCOR
0.2×0.0×

Other financials

Income statement

See full
Revenue$50.2B+2.6%
Gross profit$44.7B+1.8%
Net income$1.8B-19.2%
EPS (diluted)$8.00-16.8%

Balance sheet

See full
Cash & equivalents$9.7B+28.8%
Total debt$31.5B+11.0%
Total equity$43.9B+3.3%
Total assets$125.83B+5.1%

Cash flow

See full
Operating cash flow$4.3B+326%
CapEx$235.0M+19.9%
Free cash flow$4.1B+399%

Valuation

See full
Market cap$84.37B-34.7%
Enterprise value$106.2B-27.8%
P/E16.1×-5.7×
P/S0.4×-0.3×

Profitability

See full
Gross margin89.2%+0.6pp
Net margin2.6%-0.6pp

Returns & leverage

See full
Return on equity12.1%-2.1pp
Debt / equity0.7×+0.1×
Current ratio1.5×0.0×

Where this comes from

Calculated from Elevance Health’s reported figures.

Based on the most recent quarter.

The official record: Elevance Health’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elevance Health's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Elevance Health's EV / sales?
Elevance Health (ELV) reported EV / sales of 0.4× in Q1 2026.
How has Elevance Health's EV / sales changed year-over-year?
Elevance Health's EV / sales decreased by 34.0% year-over-year, from 0.7× to 0.4×.
What is the long-term trend for Elevance Health's EV / sales?
Over 4 years (2021 to 2025), Elevance Health's EV / sales has grown at a -10.5% compound annual growth rate (CAGR), from 3.4× to 2.2×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.